Global biopharmaceutical company Takeda has launched an innovation capability centre (ICC) in Bengaluru, India, joining existing facilities in Slovakia and Mexico. The Bengaluru ICC will focus on ...

Takeda, a biopharmaceutical innovation player, has launched its Innovation Capability Center (ICC) in Bengaluru. The center plans to hire over 750 people across various roles in CY25. The Indian ...

Takeda-backed Ascentage Pharma Group (AAPG) has filed to raise up to $100M through a U.S. initial public offering. The Chinese drug developer didn't specify terms in its SEC filing, but indicated ...

Takeda has bolstered its neuroscience pipeline by licensing drug candidates from California biotech AcuraStem targeting PIKfyve, which is gathering attention as a drug target in amyotrophic ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Three years after it was formed as a spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals has racked up its first FDA approvals, and claimed a sizeable $260 million in new financing to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

While the Bengaluru facility will focus on research and development (R&D) and digital health solutions, it aims to become a digital biopharmaceutical company in the next 3-5 years.

“Effort is always rewarded. But the reward isn’t always what you expected.” “A lesson in suffering teaches you to be resilient.” “Whether a fish lives in a clear stream or a water ditch, so long as it ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

1 Day TAK -0.38% DJIA -0.16% S&P 500 -0.21% Health Care/Life Sciences 66.70% ...